The boom in testosterone replacement therapy is the latest sign that middle-aged men have taken to spending their way out of their mid-life crisis
There’s a hot new drug called TRT that its users take to make them feel more energetic, more alive, more aggressive and sexier, too. As with so many performance-boosters, it is catnip to financial traders. “TRT is extremely popular on Wall Street and increasingly in Canary Wharf, too,” says one anonymous insider.
Now, in the surest sign that the drug has gone mainstream, it’s on the cover of Time magazine, which claims that the TRT business is now worth $2bn a year in the United States alone, following a tenfold growth in the first decade of this century.
So what is the actual substance lurking behind those initials? Well, the first “T” stands for testosterone, and “RT” for “replacement therapy”. We’re talking about hormone replacement therapy for men.
Testosterone decline sets in from around the age of 30, with one in seven men over 50 estimated to have low ‘T’ – a phenomenon known as andropause, for which replacement therapy is available on the NHS.
Middle-aged men are scoring testosterone – a class C drug and illegal without a prescription – for exactly the same reasons that their female peers are drawn to HRT. As time goes by and levels of sex hormones drop, the middle aged can feel that their bodies are getting flabbier, their libidos are flagging and their get up and go has got up and gone.